Market Access

Personalized Medicine is the Natural Evolution of Healthcare

Personalized Medicine is the natural progression of medicine and science. If we are interested ...

Next-Generation Forecasting Must Account for Payer Controls

The market access landscape for pharmaceutical products has shifted as payers struggle to control ...

Accelerating Appropriate Access to Therapy with Centralized Patient Support

Rising patient financial obligations have led to increased patient consumerism, changing the game for ...

Are We Reaching the End of the Line for PBM Exclusion Lists?

In the rapidly evolving U.S. healthcare landscape, the pharmacy benefit manager (PBM) exclusion lists ...

Common Pitfalls to Avoid to Ensure a Successful Product Launch

After spending millions on R&D just to get a product to market—and millions more ...

What Trump’s Win Might Mean for Pharma

First, let’s acknowledge the obvious—nobody knows what Trump’s win might mean for the pharma ...

The Promise and Threat of Biosimilars

The number of biologics available in the U.S. has grown every year for the ...

The Value Crisis in Pharma

The core of pharmaceutical marketing has expanded from efficacy and safety to include value. ...